| Location |
Symbol |
Title |
MIM # |
Disorder |
Comments |
Method |
Mouse |
| 19pter-p13.1 |
FPH, MUH, HPP |
Hyperpigmentation, familial progressive |
145250 |
Hyperpigmentation, familial progressive (2) |
|
Fd |
|
| 19pter-q13 |
CXB3S |
Coxsackie virus B3 sensitivity |
120050 |
|
|
S |
|
| 19pter-q12 |
EEF2, EF2 |
Eukaryotic translation elongation factor-2 |
130610 |
|
|
S |
|
| 19p13.3 |
ABCA7, ABCX |
ATP-binding cassette, subfamily A, member 7 |
605414 |
|
|
REc |
|
| 19p13.3 |
AES |
Amino-terminal enhancer of split |
600188 |
|
|
REa, A |
|
| 19p13.3 |
ANGPTL4, PGAR, HFARP, FIAF |
Angiopoietin-like 4 |
605910 |
{Reduced triglycerides, susceptibility to} (3) |
|
R |
|
| 19p13.3 |
APC2, APCL |
APC2 gene |
612034 |
|
|
A, H |
10(Apc2) |
| 19p13.3 |
IS1, AIS |
Adolescent idiopathic scoliosis |
181800 |
Scoliosis, idiopathic 1 (2) |
|
Fd |
|
| 19p13.3 |
ATCAY, CLAC, KIAA1872 |
Caytaxin |
608179 |
Ataxia, cerebellar, Cayman type, 601238 (3) |
|
REc, Fd, H |
10(ji) |
| 19p13.3 |
ATP8B3, ATPIK |
ATPase, class I, type 8B, member 3 |
605866 |
|
|
REc |
|
| 19p13.3 |
AZU1, CAP37 |
Azurocidin-1 (cationic antimicrobial protein-37) |
162815 |
|
5\(rm-AZU1-8kb-PR3-3kb-ELAN-3' |
A, REn |
|
| 19p13.3 |
BSG |
Basigin (blood group OK) |
109480 |
[Blood group, OK], 111380 (3) |
|
A |
10(Bsg) |
| 19p13.3 |
C19orf6 |
Membralin |
611011 |
|
|
REc |
10(Orf61) |
| 19p13.3 |
C19orf10, SF20, IL25 |
Stroma-derived growth factor 20 |
606746 |
|
|
REc |
17(Il25) |
| 19p13.3 |
CAPS |
Calcyphosine |
114212 |
|
|
A |
|
| 19p13.3 |
CD209, CDSIGN |
CD209 antigen |
604672 |
{Dengue fever, protection against} (3); {HIV type 1, susceptibilityto}, 609423 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3) |
|
R |
|
| 19p13.3 |
CDC34 |
Cell division cycle 34 |
116948 |
|
|
A |
|
| 19p13.3 |
CFD, ADN |
Complement factor D |
134350 |
Complement factor D deficiency (3) |
|
REc |
|
| 19p13.3 |
CIRBP |
Cold-inducible RNA-binding protein |
602649 |
|
|
A |
|
| 19p13.3 |
CLEC4M, CD209L, LSIGN, DCSIGNR |
C-type lectin domain family 4, member M |
605872 |
SARS infection, protection against (2) |
|
R |
|
| 19p13.3 |
CLPP |
ATP-dependent protease ClpAP, E. coli, proteolytic subunit, homolog of |
601119 |
|
|
REa, REc |
|